OQROSign up free
Fund moves

Structure Therapeutics (GPCR): Paradigm Biocapital Advisors LP opened a new position $26.3M

Paradigm Biocapital Advisors LP opened a new position in Structure Therapeutics, per its Q1 2026 13F.

545K
Shares reported
0.54%
Disclosed portfolio weight
$26.3M
Reported value
Holdings as of
Mar 31, 2026
Filed
May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 15, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Departure of Director or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Matthew Lang was appointed as Structure Therapeutics, Inc.’s (the “Company”) Chief Operating Officer and General Counsel, effective April 15, 2026.”
  2. May 7, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 1 more item)

What came next

  1. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Structure Therapeutics

OQRO holds no insider, Congress, fund or contract record for Structure Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GPCR page.

How this filing works

Explore the data

Other disclosures at Structure Therapeutics

Everything OQRO holds on this company is on its GPCR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data